9.84
89 Bio Inc stock is traded at $9.84, with a volume of 2.37M.
It is up +0.31% in the last 24 hours and up +30.33% over the past month.
89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).
See More
Previous Close:
$9.81
Open:
$9.66
24h Volume:
2.37M
Relative Volume:
1.21
Market Cap:
$1.44B
Revenue:
-
Net Income/Loss:
$-174.61M
P/E Ratio:
-4.9949
EPS:
-1.97
Net Cash Flow:
$-165.54M
1W Performance:
+3.69%
1M Performance:
+30.33%
6M Performance:
+9.45%
1Y Performance:
+26.48%
89 Bio Inc Stock (ETNB) Company Profile
Name
89 Bio Inc
Sector
Industry
Phone
(415) 432-9270
Address
655 MONTGOMERY STREET, SAN FRANCISCO, CA
Compare ETNB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ETNB
89 Bio Inc
|
9.84 | 1.39B | 0 | -174.61M | -165.54M | -1.97 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
89 Bio Inc Stock (ETNB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-14-25 | Initiated | Goldman | Neutral |
Mar-13-25 | Initiated | Citigroup | Buy |
Feb-04-25 | Initiated | Wolfe Research | Outperform |
Apr-22-24 | Resumed | BofA Securities | Buy |
Jan-12-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Oct-10-23 | Downgrade | Oppenheimer | Outperform → Perform |
Aug-28-23 | Initiated | UBS | Buy |
Jun-13-23 | Initiated | Evercore ISI | Outperform |
May-12-22 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-20-21 | Initiated | H.C. Wainwright | Buy |
Oct-26-21 | Resumed | Cantor Fitzgerald | Overweight |
Jul-29-21 | Resumed | BTIG Research | Buy |
May-25-21 | Downgrade | Raymond James | Strong Buy → Outperform |
Apr-21-21 | Initiated | Cantor Fitzgerald | Overweight |
Oct-19-20 | Initiated | Raymond James | Strong Buy |
Sep-25-20 | Upgrade | BofA Securities | Neutral → Buy |
Jul-31-20 | Initiated | Piper Sandler | Overweight |
Jul-23-20 | Initiated | BTIG Research | Buy |
Jul-07-20 | Initiated | Chardan Capital Markets | Buy |
Dec-09-19 | Initiated | BofA/Merrill | Neutral |
Dec-09-19 | Initiated | Oppenheimer | Outperform |
Dec-09-19 | Initiated | RBC Capital Mkts | Outperform |
Dec-09-19 | Initiated | SVB Leerink | Outperform |
View All
89 Bio Inc Stock (ETNB) Latest News
89bio, Inc. (NASDAQ:ETNB) Holdings Raised by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
89bio, Inc. (NASDAQ:ETNB) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
89bio Elects Directors and Approves Proposals at Annual Meeting - TipRanks
89bio holds annual meeting, directors elected - Investing.com
89bio Inc (NASDAQ: ETNB) Is A Blank Check For Growth - Stocksregister
Deutsche Bank AG Has $610,000 Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Millennium Management LLC Has $5.54 Million Stock Holdings in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio (ETNB) Price Target Slightly Reduced by BofA, Buy Rating Maintained | ETNB Stock News - GuruFocus
89bio price target lowered to $30 from $31 at BofA - TipRanks
89bio’s (ETNB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World
Is 89bio (NASDAQ:ETNB) A Risky Investment? - simplywall.st
Northern Trust Corp Increases Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
BNP Paribas Financial Markets Takes Position in 89bio, Inc. (NASDAQ:ETNB) - The AM Reporter
Will Other Major MASH Deals Follow GSK/Boston Pharma? - insights.citeline.com
Dimensional Fund Advisors LP Buys New Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Stock Holdings Increased by Price T Rowe Associates Inc. MD - Defense World
Voya Investment Management LLC Sells 1,476 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Why 89bio, Inc. (ETNB) Is Among the Best Low Priced Biotech Stocks to Buy Now - Yahoo Finance
Hsbc Holdings PLC Invests $87,000 in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Weiss Ratings Reaffirms “Sell (D-)” Rating for 89bio (NASDAQ:ETNB) - Defense World
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ETNB Stock News - GuruFocus
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
89bio, Inc. (NASDAQ:ETNB) Receives $27.25 Consensus Target Price from Analysts - Defense World
Deeper Dive: Understanding 89bio Inc (ETNB) Through its Various Ratios - DWinneX
MetLife Investment Management LLC Raises Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio to Participate in Upcoming Investor Conferences - The Manila Times
89bio Schedules Double Fireside Chats: Key Updates Coming at Major Healthcare Conferences - Stock Titan
89bio Inc. Reports Q1 2025 Financial Results - TipRanks
Invesco Ltd. Acquires 3,893 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
Wells Fargo & Company MN Has $394,000 Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World
Brokers Offer Predictions for 89bio FY2025 Earnings - Defense World
Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus
89bio, Inc. SEC 10-Q Report - TradingView
89bio Inc [NASDAQ: ETNB] Sees Increase in Stock Value - knoxdaily.com
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald cuts 89bio stock target to $55; keeps overweight - Investing.com
89bio (ETNB) Poised for Success with Advancements in MASH Trials - GuruFocus
Cantor Fitzgerald Upgrades 89bio (NASDAQ:ETNB) to “Strong-Buy” - Defense World
89bio Reports First Quarter 2025 Financial Results and Corporate Updates - The Manila Times
There is no doubt that 89bio Inc (ETNB) ticks all the boxes. - Sete News
Insider’s View: Deciphering 89bio Inc (ETNB)’s Financial Health Through Ratios - DWinneX
Taking a Closer Look At 89bio Inc (ETNB) Following Its Recent Trade - knoxdaily.com
Legal & General Group Plc Sells 4,860 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World
89bio, Inc. (NASDAQ:ETNB) Holdings Trimmed by Russell Investments Group Ltd. - Defense World
89bio’s (ETNB) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
89bio Inc [ETNB] stock for 91,208 USD was sold by Le-Nguyen Quoc - knoxdaily.com
89bio, Inc. (NASDAQ:ETNB) Shares Purchased by JPMorgan Chase & Co. - Defense World
Market Watch: 89bio Inc (ETNB)’s Noteworthy Gain, Closing at 6.55 - DWinneX
A look into 89bio Inc (ETNB)’s deeper side - Sete News
89bio Sees Unusually Large Options Volume (NASDAQ:ETNB) - Defense World
89 Bio Inc Stock (ETNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):